[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.65.30. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Viewpoint
September 20, 2016

Need for a National Evaluation System for Health Technology

Author Affiliations
  • 1US Food and Drug Administration, Silver Spring, Maryland
JAMA. 2016;316(11):1153-1154. doi:10.1001/jama.2016.8708

Federal regulatory frameworks governing medical products are designed to (1) provide evidence that a product benefits patients when used as intended and should be available despite accompanying risks and (2) ensure timely access to needed therapies and diagnostics. Historically, policy makers and product developers have viewed these objectives as being in tension. However, ensuring safety, expediting patient access, and enabling innovation can be complementary goals within a regulatory framework for medical devices.

First Page Preview View Large
First page PDF preview
First page PDF preview
×